GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aligned Genetics Inc (XKRX:238120) » Definitions » Research & Development

Aligned Genetics (XKRX:238120) Research & Development : ₩2,373 Mil (TTM As of Sep. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Aligned Genetics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Aligned Genetics's Research & Development for the three months ended in Sep. 2024 was ₩641 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ₩2,373 Mil.

Aligned Genetics Research & Development Historical Data

The historical data trend for Aligned Genetics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aligned Genetics Research & Development Chart

Aligned Genetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 884.80 816.18 943.58 1,079.22 1,684.33

Aligned Genetics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 334.99 547.02 548.55 636.93 640.82

Aligned Genetics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩2,373 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aligned Genetics  (XKRX:238120) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aligned Genetics Research & Development Related Terms

Thank you for viewing the detailed overview of Aligned Genetics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Aligned Genetics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aligned Genetics Inc (XKRX:238120) » Definitions » Research & Development
Comparable Companies
XKRX:337840 XKRX:398120 XKRX:115480 XKRX:290660 XKRX:419540 XKRX:405000 XKRX:241820 XKRX:335810 XKRX:058110 XKRX:214610 ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH
Traded in Other Exchanges
N/A
Address
28 Simindaero 327 beon-gil, Floor 2nd and 3rd, Dongan-gu Anyang-si, Gyeonggi-do, KOR, 14055
Website
https://www.alignedgenetics.com
Aligned Genetics Inc is engaged in developing automated systems and imaging instruments for laboratories engaging in research with a cellular and molecular emphasis.

Aligned Genetics Headlines

No Headlines